Top image

Our Research

Here you'll find information about our Flagship programs and other projects. Use the filters below to display research of interest using one of the three categories.
  • T1 | Sydney Catalyst Supported
    David Croucher: Mapping and manipulating therapeutically induced JNK network architecture to tackle breast cancer chemoresistance
    The current generation of cancer therapies mostly target components of signalling pathways, being either small molecule inhibitors or monoclonal antibodies to cell surface receptors. It is fast be...
    Breast CancerChemo resistance
  • T2,T3 | Sydney Catalyst Supported
    Phyllis Butow & team: A sustainable and supported clinical pathway for managing anxiety and depression in cancer patients: Developing and evaluating components and testing implementation strategies
    Anxiety and depression are common in those diagnosed with cancer, causing suffering to individuals and their families and potentially increasing health services usage and decreasing adherence to t...
    PsychosocialPsychologyEvidence-based practiceClinical TrialsAnxietyDepression
  • T1 | Sydney Catalyst Supported
    CINSW RIG's and REG's
    The CINSW Research Equipment and Infrastructure Grants Program is directed to providing substantial funding for key research platforms, core equipment and capacities to enhance the cancer research...
    Research EquipmentResearch InfrastructureCINSW
  • T2 | Flagship Completed Prior June 2016
    John Simes and Team: MDT scoping project
    The aim of this research was to describe the multi-disciplinary teams (MDTs) in our consortium and to share findings with survey participants to provide them an opportunity to learn more abou...
  • T1 | Flagship Completed Prior June 2016
    Sonia Yip: Biobanking - Patient and healthcare Professional Attitudes and Experiences of universal consent (B-PPAE)
    The Biobanking Qualitative Evaluation Project was initially developed to explore patient and health professional views of universal consent for biobanking procedures. It was later expanded to canv...
    Lung cancerBiobankingConsent
  • T1,T2 | Flagship Completed Prior June 2016
    Phil Hogg and Team: Measure of Thrombotic Risk in Cancer Patients
    Thrombotic events are a major cause of death in cancer patients and are associated with worsened short‐term and long‐term survival. Prof Hogg and his team developed a new diagnostic test for ...
  • T1 | Flagship Completed Prior June 2016
    Steven Kao: LC-PLAT - Lung Cancer Cohort - a Platform to Study Serial Biospecimens and Matched Clinical Data
    The project aimed to optimise a platform for the collection of serial lung cancer tissue and blood biospecimens for research during routine clinical practice. Prospective biobanking and collection...
    Lung cancerBiobanking
  • T1,T2 | Sydney Catalyst Supported
    David Thomas & Team: Molecular Screening and Therapeutics Program (MOST)
    The rapid advance in genomic technologies presents the unprecedented opportunity to molecularly phenotype cancers and link genetic information to therapeutic opportunities for individual patients....
    Genetics/genomicsPersonalised medicineNew therapies and diagnostics
  • T2,T3 | Flagship 2 Pilot and Seed
    Jessica Lee & team: Multidisciplinary Management Of Episodic Breathlessness In Adults With Advanced Cancer - a mixed methods pilot study of a complex intervention
    This T2 project involves development and evaluation of a complex intervention to improve episodic breathlessness in adults with advanced cancer. This intervention will comprise a patient held epis...
    Clinical Trials
  • T1 | Flagship 2 Pilot and Seed
    Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma
    Immune checkpoint inhibitor therapy has provided new hope to cancer patients whose tumours have resisted conventional therapy. One of the most recent success stories has been effective treatment o...
    ImmunotherapyNew therapies and diagnosticsLung cancerMesothelioma